Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging

被引:24
|
作者
Charil, Arnaud [1 ]
Shcherbinin, Sergey [1 ]
Southekal, Sudeepti [5 ]
Devous, Michael D. [5 ]
Mintun, Mark [1 ,5 ]
Murray, Melissa E. [4 ]
Miller, Bradley B. [1 ]
Schwarz, Adam J. [1 ,2 ,3 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
[3] Indiana Univ, Dept Radiol & Imaging Sci, Indianapolis, IN 46204 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
[5] Avid Radiopharmaceut, Philadelphia, PA USA
关键词
Hippocampal sparing; limbic predominant; subtype; tau; NEUROPATHOLOGICALLY DEFINED SUBTYPES; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ATROPHY; F-18-AV-1451; PATHOLOGY; RECOMMENDATIONS; PATTERNS;
D O I
10.3233/JAD-190264
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
At autopsy, individuals with Alzheimer's disease (AD) exhibit heterogeneity in the distribution of neurofibrillary tangles in neocortical and hippocampal regions. Subtypes of AD, defined using an algorithm based on the relative number of tangle counts in these regions, have been proposed-hippocampal sparing (relative sparing of the hippocampus but high cortical load), limbic predominant (high hippocampal load but lower load in association cortices), and typical (balanced neurofibrillary tangles counts in the hippocampus and association cortices) AD-and shown to be associated with distinct antemortem clinical phenotypes. The ability to distinguish these AD subtypes from the more typical tau signature in vivo could have important implications for clinical research. Flortaucipir positron emission tomography (PET) images acquired from 45 amyloid-positive participants, defined clinically as mild cognitive impairment or AD, aged 50-92 years, 56% female, and estimated to be Braak V-VI based on their PET pattern of tau pathology, were studied. By translating the neuropathologic algorithm to flortaucipir PET scans, patterns of tau pathology consistent with autopsy findings, and with a similar prevalence, were identified in vivo. 6/45 (13%) participants were identified as hippocampal sparing and 6/45 (13%) as limbic predominant AD subtypes. Hippocampal sparing participants were significantly younger than those assigned to the other two subtypes. Worse performance on delayed recall was associated with increased hippocampal tau signal, and worse performance on the trail making test B-A was associated with lower values of the hippocampus to cortex ratio. Prospective studies can further validate the flortaucipir SUVR cut-points and the phenotype of the corresponding AD subtypes.
引用
收藏
页码:1037 / 1048
页数:12
相关论文
共 50 条
  • [31] Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease
    Phillips, Jeffrey S.
    Das, Sandhitsu R.
    McMillan, Corey T.
    Irwin, David J.
    Roll, Emily E.
    Da Re, Fulvio
    Nasrallah, Ilya M.
    Wolk, David A.
    Grossman, Murray
    HUMAN BRAIN MAPPING, 2018, 39 (02) : 691 - 708
  • [32] Distinct tau PET imaging patterns in typical and atypical Alzheimer's disease
    Sarazin, Marie
    Lagarde, Julien
    Bottlaender, Michel
    BRAIN, 2016, 139 : 1321 - 1324
  • [33] Topographical Heterogeneity of Alzheimer's Disease Based on MR Imaging, Tau PET, and Amyloid PET
    Jeon, Seun
    Kang, Jae Myeong
    Seo, Seongho
    Jeong, Hye Jin
    Funck, Thomas
    Lee, Sang-Moon
    Park, Kee Hyung
    Lee, Yeong-Bae
    Yeon, Byeong Kil
    Ldo, Tatsuo
    Okamura, Nobuyuki
    Evans, Alan C.
    Na, Duk L.
    Noh, Young
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [34] FDG PET in Alzheimer's disease subtypes
    Herholz, Karl
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 : S27 - S27
  • [35] In vivo tau staging in Alzheimer's disease
    Therriault, Joseph
    Gauthier, Serge
    Rosa-Neto, Pedro
    AGING-US, 2022, 14 (17): : 6842 - 6843
  • [36] Comparison of regional flortaucipir PET SUVr values to quantitative tau histology and quantitative tau immunoassay in patients with Alzheimer's disease pathology: A clinicopathological study
    Siderowf, Andrew
    Keene, C.
    Beach, Thomas
    Montine, Thomas
    Arora, Anupa
    Devous, Michael
    Navitsky, Michael
    Kennedy, Ian
    Joshi, Abhinay
    Pontecorvo, Michael
    Lu, Ming
    Serrano, Geidy
    Rose, Shannon
    Wilson, Angela
    Hellstern, Leanne
    Coleman, Natalie
    Mintun, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [37] Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease
    Leuzy, Antoine
    Cicognola, Claudia
    Chiotis, Konstantinos
    Saint-Aubert, Laure
    Lemoine, Laetitia
    Andreasen, Niels
    Zetterberg, Henrik
    Ye, Keqiang
    Blennow, Kaj
    Hoeglund, Kina
    Nordberg, Agneta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1152 - 1163
  • [38] Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
    Antoine Leuzy
    Claudia Cicognola
    Konstantinos Chiotis
    Laure Saint-Aubert
    Laetitia Lemoine
    Niels Andreasen
    Henrik Zetterberg
    Keqiang Ye
    Kaj Blennow
    Kina Höglund
    Agneta Nordberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1152 - 1163
  • [39] Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age-related tauopathy and Alzheimer's disease
    Josephs, Keith A.
    Tosakulwong, Nirubol
    Weigand, Stephen D.
    Graff-Radford, Jonathan
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Machulda, Mary M.
    Kantarci, Kejal
    Knopman, David S.
    Nguyen, Aivi
    Reichard, R. Ross
    Dickson, Dennis W.
    Petersen, Ronald C.
    Lowe, Val J.
    Jack Jr, Clifford R.
    Whitwell, Jennifer L.
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (757)
  • [40] Flortaucipir tau PET imaging in semantic variant primary progressive aphasia
    Makaretz, Sara J.
    Quimby, Megan
    Collins, Jessica
    Makris, Nikos
    McGinnis, Scott
    Schultz, Aaron
    Vasdev, Neil
    Johnson, Keith A.
    Dickerson, Bradford C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10): : 1024 - 1031